Hospitals boost performance with beta blocker data.
Yes, suggests a recent study in JAMA. As long as efforts to boost use of beta blockers share a few key ingredients, the particular structure of a QI effort doesn't seem to make a difference in reaching the desired goal.
D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use*; D000959:Antihypertensive Agents / Q000627:therapeutic use*; D004363:Drug Utilization; D019983:Guideline Adherence; D006761:Hospitals / Q000592:standards*; D006801:Humans; D006973:Hypertension / Q000188:drug therapy*; D007857:Leadership; D009203:Myocardial Infarction / Q000517:prevention & control*; D009937:Organizational Objectives; D010818:Practice Patterns, Physicians'; D012106:Research; D014481:United States
D000319:Adrenergic beta-Antagonists; D000959:Antihypertensive Agents